DracoBelle™ Nu (Moldavian Dragonhead Collagen Booster)

Dracocephalum moldavica
Evidence Level
Preliminary
1 Clinical Trial
3 Documented Benefits
1/5 Evidence Score

DracoBelle™ Nu is Mibelle's oral, vegan 'collagen booster' from Moldavian dragonhead (Dracocephalum moldavica), standardized to flavonoid-glucuronides. Rather than supplying collagen, it is proposed to stimulate the skin's own collagen through AMPK/FOXO signaling described in laboratory studies, and is marketed for skin hydration and density. Its human trial measured skin hydration and thickness, not collagen synthesis itself. Its branded human trial (in women) reported improved skin hydration and thickness but was published in a non-PubMed-indexed journal. Honest framing: emerging beauty-from-within ingredient with manufacturer-level human evidence.

Studied Dose Branded trial: 100 mg/day for 12 weeks. Taken as a capsule or in a beauty-from-within drink/powder.
Active Compound Moldavian dragonhead (Dracocephalum moldavica) extract standardized to ≥2.5% total flavonoid-glucuronides. DracoBelle™ Nu is manufactured by Mibelle Biochemistry.

Benefits

Skin hydration and density (manufacturer trial)

Mibelle reports a double-masked, placebo-controlled trial in women (35–65) in which 100 mg/day for 12 weeks increased skin hydration and dermal/full-skin thickness. This trial is not PubMed-indexed, so weight it as manufacturer evidence.

Proposed to support the skin's own collagen (vegan)

DracoBelle Nu supplies no collagen: the idea is that it upregulates the skin's own collagen synthesis, a mechanism shown so far only in laboratory work and not measured in the human trial, which recorded hydration and skin thickness. It suits vegan beauty-from-within products.

Dragonhead flavonoid antioxidant signaling

Dracocephalum moldavica flavonoids show antioxidant and AMPK/FOXO-related activity in laboratory studies, the proposed basis for the skin and healthy-aging positioning.

Mechanism of action

1

Proposed endogenous collagen stimulation

The extract is proposed to enhance the skin's own collagen replenishment rather than deliver collagen peptides, via longevity (AMPK/FOXO) signaling in skin cells.

2

Flavonoid antioxidant protection

Dragonhead flavonoid-glucuronides scavenge reactive oxygen species, protecting dermal structures from oxidative aging.

Clinical trials

1
DracoBelle Nu Skin Trial (manufacturer)

Double-masked, randomized, placebo-controlled, 100 mg/day for 12 weeks. Published in a non-PubMed-indexed journal.

103 women aged 35–65

Increased skin hydration and dermal/full-skin thickness versus placebo. Treat as manufacturer evidence pending indexed publication.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated in the available trial.
Mild gastrointestinal upset possible.
Vegan and plant-derived; allergy is uncommon but possible.
Long-term and independent safety data are limited.

Important Drug interactions

No clinically documented drug interactions.
Low-interaction, plant-flavonoid profile.

Frequently asked questions about DracoBelle™ Nu (Moldavian Dragonhead Collagen Booster)

Does DracoBelle Nu contain collagen?

No. It contains no collagen: it is a vegan Moldavian dragonhead extract proposed to support the skin's own collagen production, a mechanism shown so far only in laboratory studies, not a collagen supplement. A manufacturer trial in women reported improved skin hydration and thickness over 12 weeks.

How good is the evidence?

Emerging. There is a placebo-controlled human trial, but it is manufacturer-run and published in a non-indexed journal, so DracoBelle Nu is best seen as a promising beauty-from-within ingredient backed mainly by manufacturer data plus its plant's antioxidant flavonoids.

What is DracoBelle Nu?

DracoBelle™ Nu is Mibelle's oral, vegan 'collagen booster' from Moldavian dragonhead (Dracocephalum moldavica), standardized to flavonoid-glucuronides. Rather than supplying collagen, it is proposed to stimulate the skin's own collagen through AMPK/FOXO signaling described in laboratory studies, and is marketed for ski…

What is DracoBelle Nu used for?

DracoBelle Nu is researched primarily for Hair, Skin & Nails. Mibelle reports a double-masked, placebo-controlled trial in women (35–65) in which 100 mg/day for 12 weeks increased skin hydration and dermal/full-skin thickness. This trial is not PubMed-indexed, so weight it as manufacturer evidence.

What is the recommended dosage of DracoBelle Nu?

The clinically studied dose is Branded trial: 100 mg/day for 12 weeks. Taken as a capsule or in a beauty-from-within drink/powder. Always follow the product label and check with a healthcare provider for personal advice.

Is DracoBelle Nu safe, and does it have side effects?

For most healthy adults, DracoBelle Nu is well tolerated at studied doses. Reported effects can include: Generally well tolerated in the available trial. Mild gastrointestinal upset possible. It may also interact with some medications. DracoBelle Nu is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does DracoBelle Nu interact with any medications?

Possible interactions include: No clinically documented drug interactions. Low-interaction, plant-flavonoid profile. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for DracoBelle Nu?

NutraSmarts rates the evidence for DracoBelle Nu as Preliminary (1 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Sun X, Ge N, Liang Q, Wang Q, Yu H, Jin M Effect of the total flavonoids of Dracocephalum moldavica L. on metabolic associated fatty liver disease in rats. Frontiers in Pharmacology. 2025;16:1549515. doi: 10.3389/fphar.2025.1549515.PubMedUsed to support: A 2025 study in rats reported that the total flavonoids of Dracocephalum moldavica reduced systemic inflammation and improved serum and liver lipid disturbances in a high-fat-diet fatty-liver model. It characterizes the plant's flavonoids but was a liver study in rats, not a skin study and not done in humans.
  2. Talebi M, Ayatollahi SA, As'Habi MA, Kobarfard F, Khoramjouy M, Boroujeni FN, et al. Investigating the neuroprotective effects of Dracocephalum moldavica extract and its effect on metabolomic profile of rat model of sporadic Alzheimer's disease. Heliyon. 2025;11(3):e42412. doi: 10.1016/j.heliyon.2025.e42412.PubMedUsed to support: A 2025 study reported antioxidant and neuroprotective effects of Dracocephalum moldavica extract in a rat model of sporadic Alzheimer's disease. It is off-target background on the plant's bioactivity in the brain, not a skin study and not done in humans.
  3. Choi B, Glávits R, Clewell A, Endres JR, Hirka G, Vértesi A, Béres E, Szakonyiné IP. An Evaluation of Genotoxicity and 90-Day Repeated-Dose Oral Toxicity in Rats of DracoBelle Nu sd. Food Sci Nutr. 2025;13(10):e71060. doi: 10.1002/fsn3.71060.PubMedUsed to support: An oral safety evaluation of DracoBelle Nu spray-dried extract found no mutagenic activity in a bacterial reverse mutation test, no clastogenic or aneugenic activity in a mouse micronucleus assay, and no adverse effects in a 90-day feeding study in rats, with a No Observed Adverse Effect Level of 1000 mg/kg body weight per day. This is animal safety data from a sponsor-contracted laboratory, not a human or skin-efficacy study.